BASE Demoprojekt

Dies ist ein Demoprojekt. Es dient Ihnen als Grundlage für den Aufbau individueller Seiten mit Weblication® CMS.

Die Seitenstruktur, das Layout und die von den Redakteuren nutzbaren Seitenelemente können Sie frei definieren.

Table of Contents

Insight into the most comprehensive Market Report "Pharma Automation Markets 2020".

 
  • 1. EXECUTIVE SUMMARY
    1
    • 1.1 Pharmaceutical Automation Markets
      3
    • 1.2 Technology Trends
      7
    • 1.3 Strategies
      12
  • 2 AIM AND SCOPE, DEFINITIONS, EXCLUSIONS
    17
    • 2.1 Aim and Scope
      19
    • 2.2 Definitions and Exclusions
      20
      • 2.2.1 Country Definitions and their Attribution to Regions
        20
      • 2.2.2 Production Values and Shipments
        21
      • 2.2.3 Capital Expenditures
        22
      • 2.2.4 Production Investments
        25
      • 2.2.5 Production Project Costs
        27
      • 2.2.6 Production Operating Expenses
        28
    • 2.3 Segmentation of Automation Markets
      28
  • 3 METHODOLOGY, ASSUMPTIONS AND SOURCES OF INFORMATION
    37
    • 3.1 Methodology
      39
    • 3.2 Important Assumptions
      41
    • 3.3 Sources of Information
      43
  • 4 AUTOMATION MARKETS FOR THE PHARMACEUTICAL INDUSTRY: OVERVIEW (100 PAGES)
    49
    • 4.1 Pharmaceutical Industry - Basics
      51
      • 4.1.1 Scope and Definitions
        51
      • 4.1.2 Industry Codes of Relevance
        56
      • 4.1.3 Processes Involved
        58
      • 4.1.4 Overall Trends in the Pharmaceutical Industry
        60
      • 4.1.5 Stimulating Factors and Barriers for Pharmaceutical Markets
        64
    • 4.2 Worldwide Production Development in the Pharmaceutical Industry until 2020
      66
      • 4.2.1 Overview
        66
      • 4.2.2 Active Pharmaceutical Ingredients (APIs)
        66
      • 4.2.3 Pharmaceutical Preparations (excl. APIs)s
        67
      • 4.2.4 Therapeutic Drugs
        68
      • 4.2.5 Diagnostic Drugs
        69
    • 4.3 Worldwide Development of Capital Expenditures in the Pharmaceutical Industry until 2020
      75
      • 4.3.1 Overview
        75
      • 4.3.2 Capital Expenditures for Synthetic & Botanical Pharmaceuticals
        77
      • 4.3.3 Capital Expenditures for Biologic Pharmaceuticals
        78
      • 4.3.4 Production Investments in Pharmaceuticals
        79
      • 4.3.5 Production Investments by Types of Investments
        80
      • 4.3.6 External Project and Maintenance Expenditures by Supplier Structure
        80
    • 4.4 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020
      91
      • 4.4.1 Share of Automation in the Pharmaceutical Industry: Project Costs
        91
      • 4.4.2 Plant Trends in the Pharmaceutical Industry
        91
      • 4.4.3 Automation Trends in the Pharmaceutical Industry
        93
      • 4.4.4 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Total Market/External Demand
        99
      • 4.4.5 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Total Market/External Demand
        100
      • 4.4.6 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Project Phase
        100
      • 4.4.7 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Operation Phase
        101
      • 4.4.8 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020 by Core and Auxiliary Processes
        101
      • 4.4.9 Worldwide Market Development of Automation Hardware for the Pharmaceutical Industry until 2020
        113
      • 4.4.10 Worldwide Market Development of Control Level Hardware for the Pharmaceutical Industry until 2020
        113
      • 4.4.11 Worldwide Market Development of Instrumentation Level Hardware for the Pharmaceutical Industry until 2020
        114
      • 4.4.12 Worldwide Market Development of Automation Software for the Pharmaceutical Industry until 2020
        115
      • 4.4.13 Worldwide Market Development of Automation Services for the Pharmaceutical Industry until 2020
        115
      • 4.4.14 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020 by Pharmaceutical Industry Subsectors until 2020
        116
      • 4.4.15 Worldwide Market Development of Automation for the Pharmaceutical Industry in 2010 by Distribution Channels
        117
  • 5 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC PATENTED DRUGS
    145
    • 5.1 Worldwide Production Development of Synthetic Patented Drugs until 2020
      147
    • 5.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Patented Drugs until 2020
      147
    • 5.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020
      154
      • 5.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Total Market/External Demand
        154
      • 5.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Total Market/External and Internal Demand
        155
      • 5.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Project Phase
        155
      • 5.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Operation Phase
        156
      • 5.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020 by Core and Auxiliary Processes
        156
      • 5.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        169
      • 5.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        169
      • 5.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        170
      • 5.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Synthetic Patented Drugs until 2020
        171
      • 5.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
        171
  • 6 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC PATENTED DRUGS
    195
    • 6.1 Worldwide Production Development of APIs for Synthetic Patented Drugs until 2020 (Open Market)
      197
    • 6.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Patented Drugs until 2020
      197
    • 6.3 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020
      204
      • 6.3.1 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Total Market/External Demand
        204
      • 6.3.2 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Total Market/External and Internal Demand
        205
      • 6.3.3 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Project Phase
        205
      • 6.3.4 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Operation Phase
        206
      • 6.3.5 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020 by Core and Auxiliary Processes
        206
      • 6.3.6 Worldwide Market Development of Automation Hardware for APIs of Synthetic Patented Drugs until 2020
        219
      • 6.3.7 Worldwide Market Development of Control Level Hardware for APIs of Synthetic Patented Drugs until 2020
        219
      • 6.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Synthetic Patented Drugs until 2020
        220
      • 6.3.9 Worldwide Market Development of Automation Software for APIs of Synthetic Patented Drugs until 2020
        221
      • 6.3.10 Worldwide Market Development of Automation Services for APIs of Synthetic Patented Drugs until 2020
        221
  • 7 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC GENERIC DRUGS
    245
    • 7.1 Worldwide Production Development of Synthetic Generic Drugs until 2020
      247
    • 7.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Generic Drugs until 2020
      247
    • 7.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020
      254
      • 7.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Total Market/External Demand
        254
      • 7.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Total Market/External and Internal Demand
        255
      • 7.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Project Phase
        255
      • 7.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Operation Phase
        256
      • 7.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020 by Core and Auxiliary Processes
        256
      • 7.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        269
      • 7.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        269
      • 7.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        270
      • 7.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Synthetic Generic Drugs until 2020
        271
      • 7.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
        271
  • 8 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC GENERIC DRUGS
    295
    • 8.1 Worldwide Production Development of APIs for Synthetic Generic Drugs until 2020 (Open Market)
      297
    • 8.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Generic Drugs until 2020
      297
    • 8.3 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020
      304
      • 8.3.1 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Total Market/External Demand
        304
      • 8.3.2 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Total Market/External and Internal Demand
        305
      • 8.3.3 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Project Phase
        305
      • 8.3.4 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Operation Phase
        306
      • 8.3.5 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020 by Core and Auxiliary Processes
        306
      • 8.3.6 Worldwide Market Development of Automation Hardware for APIs of Synthetic Generic Drugs until 2020
        319
      • 8.3.7 Worldwide Market Development of Control Level Hardware for APIs of Synthetic Generic Drugs until 2020
        319
      • 8.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Synthetic Generic Drugs until 2020
        320
      • 8.3.9 Worldwide Market Development of Automation Software for APIs of Synthetic Generic Drugs until 2020
        321
      • 8.3.10 Worldwide Market Development of Automation Services for APIs of Synthetic Generic Drugs until 2020
        321
  • 9 AUTOMATION MARKETS FOR TRADITIONAL DIAGNOSTIC DRUGS
    345
    • 9.1 Worldwide Production Development of Traditional Diagnostic Drugs until 2020
      347
    • 9.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Diagnostic Drugs until 2020
      347
    • 9.3 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020
      354
      • 9.3.1 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Total Market/External Demand
        354
      • 9.3.2 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Total Market/External and Internal Demand
        355
      • 9.3.3 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Project Phase
        355
      • 9.3.4 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Operation Phase
        356
      • 9.3.5 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020 by Core and Auxiliary Processes
        356
      • 9.3.6 Worldwide Market Development of Automation Hardware for TraditionalDiagnostic Generic Drugs until 2020
        369
      • 9.3.7 Worldwide Market Development of Control Level Hardware for Traditional Diagnostic Generic Drugs until 2020
        369
      • 9.3.8 Worldwide Market Development of Instrumentation Level Hardware for Traditional Diagnostic Drugs until 2020
        370
      • 9.3.9 Worldwide Market Development of Automation Software for Traditional Diagnostic Drugs until 2020
        371
      • 9.3.10 Worldwide Market Development of Automation Services for Traditional Diagnostic Drugs until 2020
        371
  • 10 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF BIOPHARMACEUTICAL PATENTED DRUGS
    395
    • 10.1 Worldwide Production Development of Biopharmaceutical Patented Drugs until 2020
      397
    • 10.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
      397
    • 10.3 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
      404
      • 10.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Total Market/External Demand
        404
      • 10.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Total Market/External and Internal Demand
        405
      • 10.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Project Phase
        405
      • 10.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Operation Phase
        406
      • 10.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020 by Core and Auxiliary Processes
        406
      • 10.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        419
      • 10.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        419
      • 10.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        420
      • 10.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        421
      • 10.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        421
  • 11 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOPHARMACEUTICAL PATENTED DRUGS
    445
    • 11.1 Worldwide Production Development of APIs for Biopharmaceutical Patented Drugs until 2020 (Open Market)
      447
    • 11.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biopharmaceutical Patented Drugs until 2020
      447
    • 11.3 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020
      454
      • 11.3.1 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Total Market/External Demand
        454
      • 11.3.2 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Total Market/External and Internal Demand
        455
      • 11.3.3 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Project Phase
        455
      • 11.3.4 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Operation Phase
        456
      • 11.3.5 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020 by Core and Auxiliary Processes
        456
      • 11.3.6 Worldwide Market Development of Automation Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        469
      • 11.3.7 Worldwide Market Development of Control Level Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        469
      • 11.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        470
      • 11.3.9 Worldwide Market Development of Automation Software for APIs of Biopharmaceutical Patented Drugs until 2020
        471
      • 11.3.10 Worldwide Market Development of Automation Services for APIs of Biopharmaceutical Patented Drugs until 2020
        471
  • 12 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF BIOSIMILAR DRUGS
    495
    • 12.1 Worldwide Production Development of Biosimilar Drugs until 2020
      497
    • 12.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biosimilar Drugs until 2020
      497
    • 12.3 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020
      504
      • 12.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Total Market/External Demand
        504
      • 12.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Total Market/External and Internal Demand
        505
      • 12.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Project Phase
        505
      • 12.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Operation Phase
        506
      • 12.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020 by Core and Auxiliary Processes
        506
      • 12.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        519
      • 12.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        519
      • 12.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        520
      • 12.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Biosimilar Drugs until 2020
        521
      • 12.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Biosimilar Drugs until 2020
        521
  • 13 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOSIMILAR DRUGS
    545
    • 13.1 Worldwide Production Development of APIs for Biosimilar Drugs until 2020 (Open Market)
      547
    • 13.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biosimilar Drugs until 2020
      547
    • 13.3 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020
      554
      • 13.3.1 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Total Market/External Demand
        554
      • 13.3.2 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Total Market/External and Internal Demand
        555
      • 13.3.3 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Project Phase
        555
      • 13.3.4 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Operation Phase
        556
      • 13.3.5 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020 by Core and Auxiliary Processes
        556
      • 13.3.6 Worldwide Market Development of Automation Hardware for APIs of Biosimilar Drugs until 2020
        569
      • 13.3.7 Worldwide Market Development of Control Level Hardware for APIs of Biosimilar Drugs until 2020
        569
      • 13.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Biosimilar Drugs until 2020
        570
      • 13.3.9 Worldwide Market Development of Automation Software for APIs of Biosimilar Drugs until 2020
        571
      • 13.3.10 Worldwide Market Development of Automation Services for APIs of Biosimilar Drugs until 2020
        571
  • 14 AUTOMATION MARKETS FOR MOLECULAR DIAGNOSTIC DRUGS
    595
    • 14.1 Worldwide Production Development of Molecular Diagnostic Drugs until 2020
      597
    • 14.2 Worldwide Development of Capital Expenditures and Production Investments for Molecular Diagnostic Drugs until 2020
      597
    • 14.3 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020
      604
      • 14.3.1 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Total Market/External Demand
        604
      • 14.3.2 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Total Market/External and Internal Demand
        605
      • 14.3.3 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Project Phase
        605
      • 14.3.4 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Operation Phase
        606
      • 14.3.5 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020 by Core and Auxiliary Processes
        606
      • 14.3.6 Worldwide Market Development of Automation Hardware for Molecular Diagnostic Generic Drugs until 2020
        619
      • 14.3.7 Worldwide Market Development of Control Level Hardware for Molecular Diagnostic Generic Drugs until 2020
        619
      • 14.3.8 Worldwide Market Development of Instrumentation Level Hardware for Molecular Diagnostic Drugs until 2020
        620
      • 14.3.9 Worldwide Market Development of Automation Software for Molecular Diagnostic Drugs until 2020
        621
      • 14.3.10 Worldwide Market Development of Automation Services for Molecular Diagnostic Drugs until 2020
        621
  • 15 AUTOMATION MARKETS FOR TRADITIONAL BIOLOGICALS
    645
    • 15.1 Worldwide Production Development of Traditional Biologicals until 2020
      647
    • 15.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Biologicals until 2020
      647
    • 15.3 Worldwide Market Development of Automation for Traditional Biologicals until 2020
      654
      • 15.3.1 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Total Market/External Demand
        654
      • 15.3.2 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Total Market/External and Internal Demand
        655
      • 15.3.3 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Project Phase
        655
      • 15.3.4 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Operation Phase
        656
      • 15.3.5 Worldwide Market Development of Automation for Traditional Biologicals until 2020 by Core and Auxiliary Processes
        656
      • 15.3.6 Worldwide Market Development of Automation Hardware for Traditional Biologicals Drugs until 2020
        669
      • 15.3.7 Worldwide Market Development of Control Level Hardware for Traditional Biologicals until 2020
        669
      • 15.3.8 Worldwide Market Development of Instrumentation Level Hardware for Traditional Biologicals until 2020
        670
      • 15.3.9 Worldwide Market Development of Automation Software for Traditional Biologicals until 2020
        671
      • 15.3.10 Worldwide Market Development of Automation Services for Traditional Biologicals until 2020
        671
  • 16 AUTOMATION MARKETS FOR OUTSOURCED AUXILIARY PROCESSES
    695
    • 16.1 Basics and Definitions
      697
    • 16.2 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020
      698
      • 16.2.1 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Total Market/External Demand
        698
      • 16.2.2 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Total Market/External and Internal Demand
        699
      • 16.2.3 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Project Phase
        699
      • 16.2.4 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Operation Phase
        700
      • 16.2.5 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020 by Auxiliary Processes
        700
      • 16.2.6 Worldwide Market Development of Automation Hardware for Outsourced Auxiliary Processes until 2020
        713
      • 16.2.7 Worldwide Market Development of Control Level Hardware for Outsourced Auxiliary Processes until 2020
        713
      • 16.2.8 Worldwide Market Development of Instrumentation Level Hardware for Outsourced Auxiliary Processes until 2020
        714
      • 16.2.9 Worldwide Market Development of Automation Software for Outsourced Auxiliary Processes until 2020
        715
      • 16.2.10 Worldwide Market Development of Automation Services for Outsourced Auxiliary Processes until 2020
        715
 
 
 

© INTECHNO CONSULTING Dr. Norbert Schroeder, Loerrach (Germany), 2012-2019



Market reports by

ITC Logo